JAPANESE JOURNAL OF CLINICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-09-26 johnnysn 来自上海

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：营养;胃肠外科
经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般

71 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-09-02 ms4000001835740066 来自广东省

偏重的研究方向：肿瘤;癌症
经验分享：2024-08-19投稿，至今under review，3名EO

34 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-01-25 joyeiffel 来自上海

投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投

93 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2017-10-28 lucyylx

你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表::
研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收.

kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收.

510 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2020-04-26 1489e44em82(暂无昵称)

请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表:
8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复

1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复

183 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-09-25 ms5000001962513562

快一个月了还在 AE 哭了

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2019-05-26 123e5ef9m27暂无昵称

最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表:
请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。

hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。

195 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-08-18 Doctor小雷

偏重的研究方向：癌症;肿瘤
经验分享：有大佬分享这个期刊的投稿经验吗

104 0

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 Mia

文章题目过长怎么办？

116 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2159817, encodeId=d086215981e29, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：营养;胃肠外科 经验分享：4.19 submit 6.11 大修 8.3修回 8.24 大修 8.25修回 9.25 接收期间以awaiting AE recommendation这个状态居多，效率方面一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b0c108055, createdName=johnnysn, createdTime=Tue Sep 26 15:16:44 CST 2023, time=2023-09-26, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2223717, encodeId=ca282223e17a8, content=偏重的研究方向：肿瘤;癌症 经验分享：2024-08-19投稿，至今under review，3名EO, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae149164058, createdName=ms4000001835740066, createdTime=Mon Sep 02 17:31:38 CST 2024, time=2024-09-02, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2111387, encodeId=af5e211138e41, content=投了个case，拒的很果断…说文章优先等级不够。现在发case好难，要么就是被拉预警的期刊，要么就不是sci，要么就是那种综合性期刊，一年刊载不了几篇case，基本都是自己本国病例…真不懂为啥要把world case给预警了…导致case好难投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e7001997822, createdName=joyeiffel, createdTime=Wed Jan 25 10:18:38 CST 2023, time=2023-01-25, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=548674, encodeId=d0e75486e4d2, content=你好.我大修上传之后.状态一直是awaiting AE recommendation.请问这个状态您经历过么?大概多久?会返回到原审稿人手中看么?kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., beContent=kfcnx 2016-04-24 发表:: 研究方向:肿瘤;癌症; 接收率:约75% 审稿时间:约2个月一审一个多月大修.提出一些中肯的建议.但是基本就是收了.大修提交后两周接收., objectType=tool_impact_factor, channel=null, level=null, likeNumber=510, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0f701619270, createdName=lucyylx, createdTime=Sat Oct 28 10:26:00 CST 2017, time=2017-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=589738, encodeId=ff74589e386e, content=请教一下版面费是怎么弄的？1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, beContent=1191578618 2020-02-24 00:00:00 发表: 8月份投的，11月大修，12月接收，感觉审稿人意见还算中肯，我中间催过几次稿，编辑那边都会很快回复, objectType=tool_impact_factor, channel=null, level=null, likeNumber=183, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ae15317246, createdName=1489e44em82(暂无昵称), createdTime=Sun Apr 26 00:00:00 CST 2020, time=2020-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2090344, encodeId=6848209034460, content=快一个月了还在 AE 哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=abdf8259299, createdName=ms5000001962513562, createdTime=Sun Sep 25 21:43:42 CST 2022, time=2022-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571497, encodeId=2c985e14970f, content=最后有没有投meta啊，看上面好像meta只收约稿hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, beContent=hemeifeng2009 2018-09-29 20:50:00 发表: 请问各位前辈，该杂志收不收Meta分析？本人急于投稿，等待您的回答。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc892446196, createdName=123e5ef9m27暂无昵称, createdTime=Sun May 26 00:00:00 CST 2019, time=2019-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1239575, encodeId=31ca12395e5c6, content=偏重的研究方向：癌症;肿瘤 经验分享：有大佬分享这个期刊的投稿经验吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 18 18:46:01 CST 2022, time=2022-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094518, encodeId=058b10945180b, content=文章题目过长怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094517, encodeId=4534109451e50, content=文章题目一般要求几个字？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 小动量

文章题目一般要求几个字？

115 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务